Precision Nudging for Hypertension Management: Observational Study
- Disease/Condition
- Hypertension
- Drug/Device/Intervention
- Precision Nudging for Hypertension Management
- Study type
- Observational
- Intervention type
- behavioral
- Primary sponsor
- Lirio
- Phase
- N/A
- Start date
- Apr 11, 2024
- End date
- Oct 11, 2026
- Enrollment
- 12000 participants
Clinical encounter behavioral outcome,Blood pressure reading clinical outcome
The purpose of the proposed observational study is to explore the relations between
 data-driven personalization and equitable health outcomes in a digital health intervention
 (DHI) for hypertension management. In the current intervention, behavioral reinforcement
 learning is applied to personalize intervention content to maximize the behavioral outcomes
 of three target behaviors critical for effective hypertension management: clinical
 encounters, medication adherence, and self-monitoring of blood pressure (SMBP).
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06354192
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06354192 through Pure Global AI's free database. This phase not specified trial is sponsored by Lirio and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 12000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.